New Metastasis-Suppressor Gene

Shtivelman, Emma

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 1R01CA071422-01
• Application #: 2115051
• Study Section: Pathology B Study Section (PTHB)
• Project Start: 1996-07-15
• Project End: 2000-04-30
• Budget Start: 1996-07-15
• Budget End: 1997-04-30
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: California Pacific Medical Center Research Institute
• City: San Francisco
• State: CA
• Country: United States
• Zip Code: 94107

Publications

NicAmhlaoibh, R; Shtivelman, E (2001) Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro. Oncogene 20:270-5

Whitman, S; Wang, X; Shalaby, R et al. (2000) Alternatively spliced products CC3 and TC3 have opposing effects on apoptosis. Mol Cell Biol 20:583-93

Liu, Y; Thor, A; Shtivelman, E et al. (1999) Systemic gene delivery expands the repertoire of effective antiangiogenic agents. J Biol Chem 274:13338-44

Shtivelman, E (1997) A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene 14:2167-73